Ph.D. (Biochemistry)

1. Cancer Biology
2. Cancer immunology
3. Proteomics
4. Metabolomics
5. Early diagnosis
6. Tumor markers

• Life time member, Indian Association for Cancer Research (ID LM-1102)
• Life time member, Indian society of atherosclerosis research (ID 545)
• Active Member, International Association for the Study of Lung Cancer (ID 517150)
• Associate Member, American Association for Cancer Research (ID 156975)

1. Prasad P, Chongtham J, Tripathi SC, Ganguly NK, Mittal SA, Srivastava T. Targeted inhibition of NRF2 reduces the invasive and metastatic ability of HIP1 depleted lung cancer cells. BBRC, 150676. https://doi.org/10.1016/j.bbrc.2024.150676
2. Noronha V, Budukh A, Chaturvedi P, Anne S, Punjabi A, Bhaskar M, Sahoo TP, Menon N, Shah M, Batra U, Nathany S, Kumar R, Shetty O, Ghodke TP, Mahajan A, Chakrabarty N, Hait S, Tripathi SC, …., Dutt A, Prabhash K. Uniqueness of lung cancer in Southeast Asia. Lancet Reg Health Southeast Asia. 2024 Jul 8;27:100430. doi: https://doi.org/10.1016/j.lansea.2024.100430. PMID: 39157507; PMCID: PMC11328770
3. Pajai S, John JE and Tripathi SC. Targeting immune-onco-metabolism for precision cancer therapy. Front. Oncol. 2023 Feb; 13:1124715. doi: https://doi.org/10.3389/fonc.2023.1124715.
4. Li YJ, Fahrmann JF, Aftabizadeh M, Zhao Q, Tripathi SC, Zhang C, Yuan Y, Ann D, Hanash S, Yu H. Fatty acid oxidation protects cancer cells from apoptosis by increasing mitochondrial membrane lipids. Cell Rep. 2022 May 31;39(9):110870. doi: https://doi.org/10.1016/j.celrep.2022.110870.   PMID: 35649368.
5. Tripathi SC, Vedpathak D, Ostrin EJ. The Functional and Mechanistic Roles of Immunoproteasome Subunits in Cancer. Cells. 2021 Dec 20;10(12),3587; https://doi.org/10.3390/cells10123587

1. “Biology of Some Specialized Cells: Cancer”. Cytology: An Introduction and Analysis. Koshal Publications. Jan 2020

2. Tripathi, S.C., Fahrmann, J., Amle, D. (2022). Targeting the Immuno-Oncology Metabolism in Cancer. In: Macha, M.A., Bhat, A.A., Wani, N.A. (eds) Immuno-Oncology Crosstalk and Metabolism. 2022 May 17; pp 117–152; Springer, Singapore. https://doi.org/10.1007/978-981-16-6226-3_5

3. “Biomarkers for early detection of Cancer: A proteomic approach”. Biomarkers in Cancer: Discovery, Technologies and Applications. Springer Nature publications.

Books (edited and written)

Advances in Cancer Proteomics: Where do we stand? OMICS Group International

EDITORIAL AND REVIEW ACTIVITIES

Editor/Service on Editorial Board(s)

1. Scientific Reports
2. Frontiers in Molecular Biosciences
3. Frontiers in Oncology
4. Interventions in Gynecology and Women’s Healthcare

Member of Editorial Review Board

1. Frontiers Cell and Developmental Biology

Journal Reviewer

1. Aging
2. Anti-Cancer Agents in Medicinal Chemistry
3. Asian Pacific Journal of Cancer Prevention
4. BMC Pulmonary Medicine
5. Nature communications
6. Cancer Cell International
7. Cancer Reports
8. Frontiers in Oncology
9. Frontiers in Molecular biosciences
10. Journal of Proteomic Research
11. Journal of Cellular Physiology
12. Medicine
13. Plos One
14. Scientific Reports

1. Google Scholar Profile: https://scholar.google.com/citations?user=0nvUxr0AAAAJ&hl=en&oi=ao

2. Pubmed profile: https://pubmed.ncbi.nlm.nih.gov/?term=satyendra+tripathi

1. Dr. Awtar Krishan Award at Hybrid 23rd INDO-US Flowcytometry Workshop held on 7th– 10th March 2022, Rajashthan, India.
2. Scholar in Training Award in AACR-IASLC International Joint Conference on “Lung Cancer Translational Science from the Bench to the Clinic” held on 4th-7th January 2016, San Diego, California, USA.
3. Scholar in Training Award in AACR-NCI-EORTC International Conference on “Molecular Targets and Cancer Therapeutics” held on 12th-16th November 2011, San Francisco, California, USA
4. Scholar in Training Award in AACR International Conference on “The Future of Molecular Epidemiology: New Tools, Biomarkers, and Opportunities” held on 6th-9th June 2010, Miami, Florida, USA.
5. Scholar in Training Award in Eighth Annual AACR International Conference on “Frontiers in Cancer Prevention Research” held on 6th-9th Dec 2009 at Houston, Texas, USA.
6. Young Investigator Travel Award in HUPO2009 World congress on “Proteomics of Human Health: Environment and Diseases” held on 26th-30th Sep 2009 at Toronto, Canada.
7. Travel Grant from Department of Science and Technology, Govt. of India for attending HUPO2009 World congress on “Proteomics of Human Health: Environment and Diseases” held on 26th-30th Sep 2009 at Toronto, Canada.
8. Travel Grant from Indian National Science Academy for attending HUPO2009 World congress on “Proteomics of Human Health: Environment and Diseases” held on 26th-30th Sep 2009 at Toronto, Canada.
9. Graduate Fellowship from Indian Council of Medical Research, Government of India- from February 2009-2011.
10. Fellowship awarded by AIR INDIA Pvt. Ltd- from July 1995-2006

Presentations at National or International Conferences

Invited

1. The Immunoproteasome: a smoking gun in cancer immunotherapy.  2nd Annual conference “Emerging trends in translational oncology” 02/2022. NCI (Jhajjar), AIIMS Delhi.
2. Polo-like kinase 1 inhibition potentiates radiation effect in GBM cells. 39th Annual Conference of Indian Association of Cancer Research (IACR-2020). Thiruvananthapuram, Kerala, India. 02/2020
3. Loss of immunoproteasome driven by EMT is associated with immune evasion and poor prognosis in non-small cell lung cancer. Fourth AACR-IASLC International Joint Conference: Lung Cancer Translational Science from the Bench to the Clinic. San Diego, CA, USA. 01/2016
4. Immunoproteasomes: a different strategy to treat lung cancer. Department of Stem Cell Transplantation & Cellular Therapy: Seminar Series. Houston, TX, USA 09/2014